Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases

被引:0
作者
Chad Gwaltney
Stephanie Bean
Meredith Venerus
Lisa Karlsson
Natalie Warholic
Lise Kjems
Patrick Horn
机构
[1] Gwaltney Consulting,Patient
[2] IQVIA,Centered Solutions
[3] IQVIA,Patient
[4] Albireo Pharma,Centered Solutions
[5] Inc.,undefined
来源
Advances in Therapy | 2022年 / 39卷
关键词
Cholestasis; Outcome assessment; Caregivers; Patient-reported outcome measures;
D O I
暂无
中图分类号
学科分类号
摘要
Bile, a greenish liquid that is made in the liver, is released into the gut to help digest food. In cholestatic liver disease (CLD), bile flow is interrupted, and bile can build up in the body. One potential effect of this buildup is pruritus, or itchiness of the skin, which can be so intense that it interferes with daily activities. In this study, interviews were done with doctors, patients, and their caregivers to develop new tools to evaluate the most impactful symptoms of CLD in children. After interviewing five doctors and 36 patients and caregivers, two questionnaires called PRUCISION were developed and refined. During this process, participants were first asked about the frequency, severity, duration, and impact of their or their child’s symptoms; pruritus was identified as the most common and disruptive symptom associated with CLD, even interfering with sleep. Then, the wording of the questionnaires was modified to make them easier to understand, particularly for younger children. The researchers also had patients do a card-sorting task to ensure that they understood the picture-based responses used in the questionnaires. Finally, more details were added to the instructions for caregivers to more clearly define scratching behaviors. In summary, the questionnaires developed in this study include the perspective of the patient or their caregiver and may be useful to see if new treatments can impact the most prominent symptoms and impacts associated with CLD.
引用
收藏
页码:5126 / 5143
页数:17
相关论文
共 200 条
  • [11] Todorova L(2016)Liver transplantation and the management of progressive familial intrahepatic cholestasis in children World J Transplant 6 278-290
  • [12] Kerkar N(2017)Patient-reported outcome and observer-reported outcome assessment in rare disease clinical trials: an ISPOR COA Emerging Good Practices Task Force report Value Health 20 838-855
  • [13] Sundaram SS(2015)Clinical outcome assessments: conceptual foundation-report of the ISPOR Clinical Outcomes Assessment—Emerging Good Practices for Outcomes Research Task Force Value Health 18 741-752
  • [14] Mack CL(2011)Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 1–eliciting concepts for a new PRO instrument Value Health 14 967-977
  • [15] Feldman AG(2011)Content validity–establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2–assessing respondent understanding Value Health 14 978-988
  • [16] Sokol RJ(2018)Biliary atresia: clinical and research challenges for the twenty-first century Hepatology 68 1163-1173
  • [17] Turnpenny PD(2017)Qualitative methods and patient-reported outcomes: measures development and adaptation Int J Qual Methods 16 1-3
  • [18] Ellard S(2012)Using pruritus grading system for measurement of pruritus in patients with diseases associated with itch J Med J 46 39-44
  • [19] Thébaut A(2009)Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool Br J Dermatol 161 1143-1148
  • [20] Debray D(2001)New aspects of itch pathophysiology: component analysis of atopic itch using the 'Eppendorf Itch Questionnaire' Int Arch Allergy Immunol 124 326-331